H

Harmony Biosciences Holdings

HRMY

32.710
USD
-1.22
(-3.60%)
مغلق
حجم التداول
211,599
الربح لكل سهم
0
العائد الربحي
0
P/E
17
حجم السوق
1,827,237,052
الأخبار المقالات

العنوان: Harmony Biosciences Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX(pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.